Back to Products
Vildagliptin & Metformin
Vilagli-M is indicated in adults with type-2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control. Vilagli-M should not be used in patients with type-1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.
Based on the patient’s current dose of Metformin, the combination of Vildagliptin & Metformin may be initiated at either 50 mg/500 mg or 50 mg/850 mg twice daily, 1 tablet in the morning and the other in the evening.The recommended daily maximum dose is 100 mg Vildagliptin & 2000 mg Metformin HCl. Doses higher than 100 mg of Vildagliptin are not recommended.
Vilagli-M 50/500 Tablet (30’s): Each box contains 30 tablets (3×10’s) in blister pack.
Vilagli-M 50/850 Tablet (10’s): Each box contains 10 tablets (1×10’s) in blister pack.
